Capital infusion in Thailand WOS, Q2 results, AGL Proteins stake sale

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

ASIANTILES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹68.50

prior close

₹69.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-3.0% vs market

Ceramics peers, median of 10sector-0.9%-2.2% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.2 pts less than its Ceramics peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.8

15m

+1.7

30m

+1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-0.1-3.0-0.9-2.2

Next day

-2.2-0.2-2.0-0.9-1.2

+0.2+0.4-0.2-1.3+1.5

-0.7-0.4-0.3-1.5+0.8

-2.2-0.6-1.6-2.0-0.2

-2.3-0.9-1.4-3.4+1.1

-5.9-3.0-2.9-5.9+0.0

15d

-8.0-3.9-4.2-7.2-0.9

-10.6-4.8-5.8-7.7-2.9

+3.6-7.8+11.4-10.2+13.9

-1.3-7.2+5.9-14.6+13.3

UpDownMarket · Nifty Microcap 250Sector · Ceramics peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 results: standalone revenue Rs 272 cr, net profit Rs 7.8 cr; consolidated revenue Rs 407 cr, net profit Rs 16.7 cr. Approved increasing capital contribution in Harmony Surfaces Thailand Limited, wholly owned subsidiary, to fund working capital and international expansion. Also approved disposal of 25% stake in AGL Proteins Private Limited to existing shareholder for Rs 25,000, reducing holding from 51% to 26%, making it an associate.

Likely market impact

Thailand capital infusion supports overseas expansion. AGL Proteins sale is minor since no operations have begun yet. Consolidated profit rose sharply year on year.